City

Helsinki (1)

Joensuu (1)

Kotka (1)

Lahti (1)

Lappeenranta (1)

Mexico City (1)

Seinajoki (1)

Condition

Antirheumatic Agents (2)

Hydroxychloroquine (2)

Acute Coronary Syndrome (1)

Antimalarials (1)

Cardiovascular Diseases (1)

Enzyme Inhibitors (1)

Inflammation (1)

Myocardial Infarction (1)

Overall Status

Completed (1)

Enrolling by invitation (1)

Sign in for free

Phase

early phase 1 (1)

phase 4 (1)

Sponsor

Helsinki University Central Hospital (1)

Instituto Nacional de Rehabilitacion (1)

Collaborator

Aarne Koskelo Foundation (1)

Finnish Cultural Foundation (1)

Finnish Foundation for Cardiovascular Research (1)

Orion Corporation, Orion Pharma (1)

Intervention

bromhexine 8 mg (1)

hydroxychloroquine (1)

hydroxychloroquine sulfate (1)

placebo (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Other (2)

Study Type

Interventional (2)

antirheumatic agents

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Hydroxychloroquine, Antimalarials, Enzyme Inhibitors Trial in Mexico City (Hydroxychloroquine Sulfate, Bromhexine 8 MG)

Enrolling by invitation

Hydroxychloroquine
+3 more

Hydroxychloroquine Sulfate
Bromhexine 8 MG

Mexico City, Cdmx, Mexico

National Institute of Rehabilitation, Luis Guillermo Ibarra Ibar

Jun 26, 2021

Myocardial Infarction, Acute Coronary Syndrome, Inflammation Trial in Finland (Hydroxychloroquine, Placebo)

Completed

Myocardial Infarction
+5 more

Hydroxychloroquine
Placebo

Helsinki, Finland
+5 more

Jun 6, 2020